• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    M

    Maaslandziekenhuis

    EST. 1908
    1,214论文总数
    2.3万引用总数

    论文量&引用量时间轴

    机构学者

    论文(1214)

    年份
    起
    –
    止
    排序
    1The Impact of Preoperative Weight Loss on Long-term Success: 5-Year Outcomes after Metabolic Bariatric Surgery
    Kayleigh A. M. van Dam, Cathelijne Kam, Marijn T. F. Jense, Geert H. J. M. Verkoulen, Pieter P. H. L. Broos, Evelien de Witte, Jan Willem M. Greve,Evert-Jan G. Boerma

    Introduction Preoperative weight loss has been suggested as a predictor of postoperative weight loss outcomes after Metabolic Bariatric Surgery (MBS). While previous studies focused on outcomes up to 3 years, longer-term results remain limited. This study evaluates the association between preoperative weight loss and total weight loss (%TWL) up to five years postoperatively. Methods This single-center retrospective study included 765 patients who underwent primary MBS between June 2017 and august 2019. Patients were stratified into quartiles based on preoperative weight loss. Follow-up data on %TWL were analyzed at 3 and 6 months and 1 through 5 years postoperatively. Results The median age was 45 (35-52) and the majority were female (76.6%). Most patients underwent ring augmented Roux-en-Y Gastric Bypass (91.1%). Follow-up was 99.6% at 1 year and 65.9% at 5 years. Quartiles were defined as Q1: <4.4%, Q2:4.4-6.2%, Q3: 6.2-8.2% and Q4: > 8.2% preoperative weight loss. After 5 years %TWL was 32.4 (Q1), 32 (Q2), 32 (Q3) and 31.6 (Q4). Conclusion Greater preoperative weight loss was associated with significant higher %TWL up to two years (quartiles) and four years (low vs high) after MBS, but no significant differences were found after five years of follow up. The impact of preoperative weight loss on long-term outcomes was consistent across subgroups. Female sex, RYGB procedure and younger age were general predictors for greater %TWL.

    2026Obesity Surgery(2026)引用:1
    引用
    AI阅读
    加入学术空间
    2Levenseindegesprekken
    Fran Peerboom, Jolanda Friesen-Storms, Jenny van der Steen,Daisy Janssen,Judith Meijers
    2026TVZ - Verpleegkunde in praktijk en wetenschap(2026)
    引用
    AI阅读
    加入学术空间
    3Response and Survival in Unresectable In-Transit Metastatic Melanoma According to Treatment Strategy.
    Cato Boreel, Jessie de Ruijter,Olivier van Not,Manja Bloem, Lukas Been,Maureen Aarts,Franchette van den Berkmortel,Christian Blank,Marye Boers-Sonderen,Han Bonenkamp,Jan-Willem de Groot,Dirk Grünhagen,

    BACKGROUND:Currently, no comprehensive overview exists of response and survival outcomes for first-line immune checkpoint inhibition, BRAF/BRAF + MEK inhibition (BRAF(/MEK)i), and talimogene laherparepvec (T-VEC) in melanoma patients with unresectable in-transit metastases (ITM). This study aims to provide a real-world overview of these outcomes. METHODS:Using data from the nationwide Dutch Melanoma Treatment Registry, all patients receiving systemic treatment from 2012 to July 2025 for unresectable ITM, with or without lymph node metastases (LNM) (stage III-IVM1a), were analysed for overall response rate (ORR), progression-free survival (PFS), overall survival (OS), and melanoma-specific survival (MSS). A multivariable Cox model adjusted for age, sex, ECOG PS, LDH, and LNM. RESULTS:In total, 530 patients were identified: 213 received first-line anti-PD1, 182 T-VEC, 67 BRAF(/MEK)i, 37 ipilimumab (IPI), and 31 ipilimumab + nivolumab (IPI+NIVO). Patients receiving T-VEC had more favorable baseline characteristics, including less often stage IV disease, less often LNM, and lower LDH. ORR were comparable between treatments: anti-PD1 53.1%, T-VEC 52.2%, BRAF(/MEK)i 62.7%. Median PFS was significantly shorter for T-VEC (5.6months; 95%CI 4.2-8.1) than for anti-PD1 (8.1months; 95%CI 5.9-13.8) and BRAF(/MEK)i (9.2months; 95%CI 6.9-14.3). Median OS favored T-VEC (not reached (NR); 95%CI 61.5-NR) over anti-PD1 (37.2months; 95%CI 32.3-64.7) and BRAF(/MEK)i (24.7months; 95%CI 18.0-62.1), but this difference between T-VEC and anti-PD1 disappeared after adjusting for confounders and no differences were observed in MSS. In the ITM-only subgroup, T-VEC-treated patients demonstrated longer observed OS than anti-PD1 and BRAF(/MEK)i, while in patients with ITM and LNM, anti-PD1 showed longer PFS but similar OS compared with T-VEC. CONCLUSIONS:For ITM unresectable melanoma, first-line anti-PD1, T-VEC, and BRAF(/MEK)i can induce clinically meaningful and durable responses. The optimal treatment choice depends on patient and disease characteristics and preferences.

    2026European journal of cancer (Oxford, England 1990)(2026)
    引用
    AI阅读
    加入学术空间
    4Safety and Effectiveness of Conversion from Adjustable Gastric Band to Ring Augmented Roux-en-Y Gastric Bypass
    Kayleigh Ann Martina van Dam, Geert Henricus Jozef Martinus Verkoulen, Evelien de Witte, Pieter Petrus Henricus Luciën Broos, Jan Willem M. Greve, Evert-Jan Gijsbert Boerma

    Laparoscopic Adjustable Gastric Band (AGB) has shown suboptimal long-term results with a non-success rate of 20–56

    2026Obesity Surgery(2026)
    引用
    AI阅读
    加入学术空间
    5Living with an Osteoporotic Vertebral Compression Fracture: a Qualitative Exploration of Patient and Healthcare Professional Perspectives
    Annemarijn Weber, Ruud Droeghaag, Agnes T. G. Paulus, Silvia M. A. A. Evers,Sander M. J. van Kuijk,Paul C. Willems,Eva Jacobs

    Osteoporotic spine fractures deeply affect patients’ lives, yet little is known about patients’ lived experiences. This qualitative study found that patients face delayed diagnosis, inconsistent care, and emotional distress, while professionals call for clearer communication and coordination. Results highlight the urgent need for more consistent, patient-centered osteoporosis care. Osteoporotic vertebral compression fractures (OVCFs) are common and often debilitating, yet patient perspectives remain underexplored. This study aimed to investigate the lived experiences of patients with OVCF and the perspectives of healthcare professionals involved in their care. A qualitative research design was used, involving 25 semi-structured interviews with postmenopausal women with a symptomatic OVCF (n = 15) and healthcare providers (n = 10) across six Dutch hospitals. Thematic analysis was performed using ATLAS.ti. After initial familiarization, data were organized into categories and subcategories. Coding was iterative, and 25

    2026Archives of Osteoporosis(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 1214 篇论文

    合作机构(100)

    马斯特里赫特大学合作论文 484
    莱顿大学合作论文 124
    奈梅亨拉德布大学合作论文 108
    格罗宁根大学医学中心合作论文 104
    阿姆斯特丹大学合作论文 104
    乌得勒支大学医学中心合作论文 86
    Catharina Ziekenhuis合作论文 76
    VieCuri Medisch Centrum合作论文 65
    St. Antonius Ziekenhuis合作论文 61
    Medical Center Leeuwarden合作论文 43

    机构统计